Literature DB >> 109055

Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.

B McConkey, P Davies, R A Crockson, A P Crockson, M Butler, T J Constable, R S Amos.   

Abstract

Sequential measurements of serum C-reactive protein (CRP), serum haptoglobin (Hp), and erythrocyte sedimentation rate (ESR) were made in 209 patients with rheumatoid arthritis (RA); 78 of them were treated with gold, 71 with dapsone, and 60 with prednisone. The results were expressed as proportional changes in the measurements at 28-day intervals after treatment began. The period of study was 140 days. During treatment with gold and dapsone there were statistically significant gradual and progressive falls of similar magnitude in serum CRP and ESR. During treatment with prednisone serum CRP and ESR fell abruptly by 28 days and thereafter altered little. At 140 days prednisone had had the largest proportional effect on both measurements. During gold treatment the fall in serum Hp was similar to that of the ESR. In contrast, prednisone had little effect on Hp levels despite large falls in serum CRP and the ESR. Either prednisone stimulates Hp synthesis or the divergence is an expression of the difference in type of effect between gold and prednisone on RA. The effect of dapsone on serum Hp was large and progressive; it partly reflects haemolysis and, since the haemolysis was not progressive, partly improvement in the RA. The results show the relative efficacy of the drugs and suggest that dapsone may be a useful alternative treatment for RA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109055      PMCID: PMC1000338          DOI: 10.1136/ard.38.2.141

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  The basis of the erythrocyte sedimentation rate.

Authors:  J HARDWICKE; J R SQUIRE
Journal:  Clin Sci       Date:  1952-11       Impact factor: 6.124

2.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

3.  The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

Authors:  B McConkey; R A Crockson; A P Crockson; A R Wilkinson
Journal:  Q J Med       Date:  1973-10

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  New drugs for inflammation - a clinical viewpoint for their assessment.

Authors:  B McConkey
Journal:  Agents Actions       Date:  1976-09

6.  Drug treatment of rheumatoid arthritis. A systematic approach.

Authors:  T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Lancet       Date:  1975-05-24       Impact factor: 79.321

7.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

8.  ESTIMATION OF SERUM HAEMOGLOBIN-BINDING CAPACITY (HAPTOGLOBIN) ON SEPHADEX G.100.

Authors:  A P RATCLIFF; J HARDWICKE
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

9.  Dapsone in rheumatoid arthritis.

Authors:  B McConkey; P Davies; R A Crockson; A P Crockson; M Butler; T J Constable
Journal:  Rheumatol Rehabil       Date:  1976-08
  9 in total
  20 in total

Review 1.  Do drugs change the course of rheumatoid arthritis?

Authors:  V Wright; R Amos
Journal:  Br Med J       Date:  1980-04-05

2.  Progression of radiological changes in rheumatoid arthritis.

Authors:  D L Scott; K A Grindulis; G R Struthers; B L Coulton; A J Popert; P A Bacon
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

3.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

4.  Inflammatory markers and mortality among US adults with obstructive lung function.

Authors:  Earl S Ford; Timothy J Cunningham; David M Mannino
Journal:  Respirology       Date:  2015-03-04       Impact factor: 6.424

5.  Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

Authors:  M D Chard; J Calvin; C P Price; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.

Authors:  M T Walters; F K Stevenson; R Goswami; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

7.  The influence of anti-rheumatic drugs on hepatic mRNA levels of acute-phase proteins in rats with adjuvant arthritis.

Authors:  T Geiger; B Jagher; W Pignat; B Tscherry; I Wiesenberg
Journal:  Agents Actions       Date:  1993

8.  Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study.

Authors:  P D Fowler; M F Shadforth; P R Crook; A Lawton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

9.  Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

Authors:  K A Grindulis; B McConkey
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Serum calcium levels in rheumatoid arthritis.

Authors:  D L Scott; M Farr; C F Hawkins; R Wilkinson; A M Bold
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.